The presence of a mutations in any of these genes: SRSF2, SF3B1, U2AF1, ZRSR2, ASXL1, EZH2, BCOR, or STAG2 was >95% specific for the diagnosis of secondary AML (88). Here, ASXL1 is linked to acute myeloid leukemia.